UBS Call 220 BNTX 21.06.2024/ DE000UL1DQX0 /
2024-05-16 6:33:48 PM | Chg.0.000 | Bid2024-05-16 | Ask2024-05-16 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.055EUR | 0.00% | 0.055 Bid Size: 25,000 |
0.220 Ask Size: 25,000 |
BioNTech SE | 220.00 USD | 2024-06-21 | Call |
GlobeNewswire
05-09
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
05-02
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
04-22
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire
04-10
Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire
04-07
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire
03-28
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
03-20
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire
03-20
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire
03-14
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire
03-12
The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...
GlobeNewswire
03-11
BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire
03-11
FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead ...
GlobeNewswire
03-11
DEADLINE ALERT for DADA, BNTX, and CMI: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire
03-11
BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline ...
GlobeNewswire
03-11
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire
03-11
BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Sub...